Lv2
106 积分 2024-01-25 加入
Spatiotemporal Delivery of Dual Nanobodies by Engineered Probiotics to Reverse Tumor Immunosuppression via Targeting Tumor-Derived Exosomes
5天前
已完结
Nociceptive innervation limits tertiary lymphoid structures to promote lung cancer
1个月前
已完结
Time-of-Day Immunotherapy Administration and Outcomes in Advanced Cancers
1个月前
已完结
Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial
1个月前
已完结
Mechanical load inhibits cancer growth in mouse and human hearts
1个月前
已完结
A conserved H3K14ub-driven H3K9me3 for chromatin compartmentalization
3个月前
已完结
Stochasticity in cancer immunotherapy stems from rare but functionally critical Spark T cells
4个月前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
4个月前
已完结
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial
4个月前
已完结
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
4个月前
已完结
皖公网安备34019202002308
